Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Capital Reinvestment Ratio
Latest as of September 2025:
0.46x
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Capital Reinvestment Ratio of 0.46x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥69.15 Million) in capital expenditures (CN¥32.02 Million). See 000153 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.46x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥69.15 Million
CNY
Capital Expenditures
CN¥32.02 Million
CNY
Data as of
Sep 2025
Most recent filing
Anhui Fengyuan Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Anhui Fengyuan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods.
Annual Capital Reinvestment Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. For live market cap and broader valuation context, see 000153 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.85x | CN¥119.30 Million | CN¥220.61 Million | ▲ +62.1% |
| 2024 | 1.14x | CN¥126.24 Million | CN¥144.02 Million | ▲ +91.1% |
| 2023 | 0.60x | CN¥254.75 Million | CN¥152.12 Million | ▲ +221.3% |
| 2022 | 0.19x | CN¥439.99 Million | CN¥81.76 Million | ▼ -71.9% |
| 2021 | 0.66x | CN¥237.88 Million | CN¥157.36 Million | ▲ +1.5% |
| 2020 | 0.65x | CN¥292.75 Million | CN¥190.74 Million | ▼ -70.4% |
| 2019 | 2.20x | CN¥66.21 Million | CN¥145.62 Million | ▲ +507.0% |
| 2018 | 0.36x | CN¥233.59 Million | CN¥84.63 Million | ▼ -60.4% |
| 2017 | 0.92x | CN¥52.40 Million | CN¥47.99 Million | ▲ +223.2% |
| 2016 | 0.28x | CN¥78.21 Million | CN¥22.17 Million | ▼ -74.4% |
| 2015 | 1.11x | CN¥45.50 Million | CN¥50.33 Million | ▼ -93.4% |
| 2014 | 16.73x | CN¥10.51 Million | CN¥175.86 Million | ▲ +703.5% |
| 2012 | 2.08x | CN¥45.65 Million | CN¥95.06 Million | ▲ +64.1% |
| 2011 | 1.27x | CN¥55.06 Million | CN¥69.86 Million | ▼ -22.2% |
| 2010 | 1.63x | CN¥55.04 Million | CN¥89.75 Million | ▼ -29.0% |
| 2009 | 2.30x | CN¥32.41 Million | CN¥74.42 Million | ▲ +262.3% |
| 2008 | 0.63x | CN¥49.82 Million | CN¥31.58 Million | ▼ -0.4% |
| 2007 | 0.64x | CN¥55.26 Million | CN¥35.18 Million | ▼ -83.1% |
| 2006 | 3.77x | CN¥36.27 Million | CN¥136.67 Million | ▲ +268.4% |
| 2005 | 1.02x | CN¥34.88 Million | CN¥35.68 Million | ▼ -88.3% |
| 2002 | 8.73x | CN¥10.48 Million | CN¥91.40 Million | ▲ +8.1% |
| 2001 | 8.07x | CN¥23.57 Million | CN¥190.24 Million | ▲ +77.3% |
| 2000 | 4.55x | CN¥25.88 Million | CN¥117.82 Million | ▲ +0.5% |
| 1999 | 4.53x | CN¥1.01 Million | CN¥4.59 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow